The severity of depression is associated with pelvic inflammatory diseases: A cross-sectional study of the United States National Health and Nutrition Examinations from 2013 to 2018

Purpose As depression in patients with pelvic inflammatory diseases (PID) has received increasing attention in recent years, this study aims to investigate the relationship between depression severity and risk factors for pelvic inflammatory disease, and to provide new perspectives in the treatment of PID. Patients and methods Multivariate regression was used to evaluate the association between pelvic inflammatory disease and the severity of depression. Females who participated in the United States National Health and Nutrition Examination Survey (NHANES) from 2013 to 2018 were included. In addition, risk factors for PID and depression were also included in the analysis as adjustment factors. Results The risk of developing PID was associated with depressive status (odds ratio, OR 1.10, 95% confidence interval, CI 1.08–1.12), especially in people with severe depression (odds ratio, OR 6.34, 95% confidence interval, CI 3.72–10.79). Subgroup analysis showed differences in the risk of PID among people with different characteristics. Conclusion This study showed that there may be a potential positive association between depressive status and the prevalence of PID in the United States adult female population. Depression should be actively looked for in all patients with PID and treated appropriately

[1]  U. Volpe,et al.  C-Reactive Protein as a Biomarker for Major Depressive Disorder? , 2022, International journal of molecular sciences.

[2]  C. Cohen,et al.  Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia. , 2021, The Journal of infectious diseases.

[3]  Elizabeth A Torrone,et al.  The Burden of and Trends in Pelvic Inflammatory Disease in the United States, 2006-2016. , 2021, The Journal of infectious diseases.

[4]  K. Bernstein,et al.  A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease. , 2021, The Journal of infectious diseases.

[5]  C. Cheung,et al.  How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders , 2021, British journal of pharmacology.

[6]  Ya-Ling Huang,et al.  TNIP2 mediates GRβ-promoted inflammation and is associated with severity of major depressive disorder , 2021, Brain, Behavior, and Immunity.

[7]  R. Marioni,et al.  Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder , 2020, Brain, Behavior, and Immunity.

[8]  Dan Huang,et al.  A Systematic Study of Mechanism of Sargentodoxa cuneata and Patrinia scabiosifolia Against Pelvic Inflammatory Disease With Dampness-Heat Stasis Syndrome via Network Pharmacology Approach , 2020, Frontiers in Pharmacology.

[9]  R. Savaris,et al.  Antibiotic therapy for pelvic inflammatory disease. , 2020, The Cochrane database of systematic reviews.

[10]  P. White,et al.  Incidence of Pelvic Inflammatory Disease Associated With Mycoplasma genitalium Infection: Evidence Synthesis of Cohort Study Data , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  C. Nemeroff,et al.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble , 2020, Neuron.

[12]  L. Mohadjer,et al.  National Health and Nutrition Examination Survey, 2015-2018: Sample Design and Estimation Procedures. , 2020, Vital and health statistics. Series 2, Data evaluation and methods research.

[13]  A. Yang,et al.  Role of Interleukin-6 in Depressive Disorder , 2020, International journal of molecular sciences.

[14]  A. Lanz,et al.  Sampling Design and Estimation Procedures , 2019, Swiss National Forest Inventory – Methods and Models of the Fourth Assessment.

[15]  R. Mackie,et al.  Double trouble. , 1989, Nursing times.